Skip to main content
Premium Trial:

Request an Annual Quote

Vermillion Granted US Patent for Lung Cancer Biomarkers


Vermillion said this week it has received a US patent covering serum protein biomarkers for lung cancer.

The patent, No. 8,014,952, entitled "Serum Biomarkers in Lung Cancer," describes 50 protein biomarkers that can be used to distinguish between patients with and without lung cancer and to determine the particular type of lung cancer.

"This patent highlights ongoing progress in expanding our intellectual property portfolio," Vermillion CEO Gail Page said in a statement. "Beyond our core focus areas of ovarian cancer and peripheral artery disease, we now have patents in lung cancer, breast cancer, and Alzheimer's disease. It is our goal to explore business opportunities to leverage this growing and valuable asset."

In addition to Vermillion, Hong Kong's Queen Elizabeth Hospital is listed as an assignee on the patent.

The Scan

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.

Clinical Trial Participants, Investigators Point to Importance of Clinical Trial Results Reporting in Canadian Study

Public reporting on clinical trial results is crucial, according to qualitative interviews with clinical trial participants, investigators, and organizers from three provinces appearing in BMJ Open.

Old Order Amish Analysis Highlights Autozygosity, Potential Ties to Blood Measures

Researchers in BMC Genomics see larger and more frequent runs-of-homozygosity in Old Order Amish participants, though only regional autozygosity coincided with two blood-based measures.

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.